Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal

The National Institute for Health and Care Excellence (NICE), as part of the institute’s single technology appraisal (STA) process, invited the company that makes obinutuzumab (Roche Products Limited) to submit evidence of the clinical and cost effectiveness of the drug in combination with chemother...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pharmacoeconomics
Main Authors: Thielen, Frederick W., Büyükkaramikli, Nasuh C., Riemsma, Rob, Fayter, Debra, Armstrong, Nigel, Wei, Ching-Yun, Huertas Carrera, Vanesa, Misso, Kate, Worthy, Gill, Kleijnen, Jos, Corro Ramos, Isaac
格式: Artigo
語言:Inglês
出版: Springer International Publishing 2018
主題:
Review Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6598743/
https://ncbi.nlm.nih.gov/pubmed/30547368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-018-0740-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍